An Illinois OTC ophthalmic drug manufacturer failed to convince the Food and Drug Administration it was keeping contaminants away from a sterile processing line and was advised to conduct a comprehensive evaluation of the effectiveness of its environmental monitoring.
A second OTC drug firm warned about not keeping production areas sufficiently sterile, a Mexican company, stopped making hand sanitizers...






